HK1049160B - 1-氨基-烷基環已烷化合物nmda受體拮抗劑 - Google Patents

1-氨基-烷基環已烷化合物nmda受體拮抗劑

Info

Publication number
HK1049160B
HK1049160B HK03101158.3A HK03101158A HK1049160B HK 1049160 B HK1049160 B HK 1049160B HK 03101158 A HK03101158 A HK 03101158A HK 1049160 B HK1049160 B HK 1049160B
Authority
HK
Hong Kong
Prior art keywords
amino
nmda receptor
compounds
alleviation
alkyl
Prior art date
Application number
HK03101158.3A
Other languages
English (en)
Other versions
HK1049160A1 (en
Inventor
M‧戈爾德
W‧達尼茨
C‧G‧R‧帕森斯
I‧卡爾溫什
V‧考斯
A‧杰根森斯
Original Assignee
莫茨藥物股份兩合公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 莫茨藥物股份兩合公司 filed Critical 莫茨藥物股份兩合公司
Publication of HK1049160A1 publication Critical patent/HK1049160A1/xx
Publication of HK1049160B publication Critical patent/HK1049160B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK03101158.3A 1999-11-01 2003-02-18 1-氨基-烷基環已烷化合物nmda受體拮抗劑 HK1049160B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1999/008317 WO2001032640A1 (en) 1999-11-01 1999-11-01 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants

Publications (2)

Publication Number Publication Date
HK1049160A1 HK1049160A1 (en) 2003-05-02
HK1049160B true HK1049160B (zh) 2006-11-17

Family

ID=8167482

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101158.3A HK1049160B (zh) 1999-11-01 2003-02-18 1-氨基-烷基環已烷化合物nmda受體拮抗劑

Country Status (24)

Country Link
EP (1) EP1228052B1 (zh)
JP (1) JP4043236B2 (zh)
KR (1) KR100548600B1 (zh)
CN (1) CN1264827C (zh)
AT (1) ATE361284T1 (zh)
AU (1) AU782760B2 (zh)
CA (1) CA2389325C (zh)
CY (1) CY1106672T1 (zh)
CZ (1) CZ20021533A3 (zh)
DE (1) DE69936004T2 (zh)
DK (1) DK1228052T3 (zh)
EA (1) EA005684B1 (zh)
ES (1) ES2285870T3 (zh)
HK (1) HK1049160B (zh)
HU (1) HUP0203275A3 (zh)
IL (2) IL149401A0 (zh)
MX (1) MXPA02004368A (zh)
NO (1) NO322359B1 (zh)
PL (1) PL199587B1 (zh)
PT (1) PT1228052E (zh)
SI (1) SI1228052T1 (zh)
TW (1) TWI242547B (zh)
UA (1) UA72558C2 (zh)
WO (1) WO2001032640A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
NZ579310A (en) 2007-03-01 2012-03-30 Probiodrug Ag Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof
DK2142514T3 (da) 2007-04-18 2015-03-23 Probiodrug Ag Thioureaderivater som glutaminylcyclase-inhibitorer
US8486940B2 (en) 2009-09-11 2013-07-16 Probiodrug Ag Inhibitors
EP2542549B1 (en) 2010-03-03 2016-05-11 Probiodrug AG Inhibitors of glutaminyl cyclase
BR112012022478B1 (pt) 2010-03-10 2021-09-21 Probiodrug Ag Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
CN104211663B (zh) * 2014-08-11 2017-01-11 杭州偶联医药科技有限公司 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
RU2714135C1 (ru) * 2019-11-22 2020-02-12 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Гидрохлорид (1-метилпиперидин-4-ил)-2-пропилпентаноата, обладающий холинолитической и противосудорожной активностью

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097207A (en) * 1958-03-06 1963-07-09 Parke Davis & Co 1-halophenyl and 1-alkoxyphenyl cyclohexylamines
PT1009732E (pt) * 1997-06-30 2003-10-31 Merz & Co Gmbh & Co 1-amino-alquilciclo-hexanos antagonistas do receptor nmda

Also Published As

Publication number Publication date
AU1158500A (en) 2001-05-14
UA72558C2 (uk) 2005-03-15
CZ20021533A3 (cs) 2002-08-14
KR100548600B1 (ko) 2006-02-01
AU782760B2 (en) 2005-08-25
NO322359B1 (no) 2006-09-18
DE69936004D1 (de) 2007-06-14
PL354519A1 (en) 2004-01-26
PL199587B1 (pl) 2008-10-31
TWI242547B (en) 2005-11-01
NO20022044L (no) 2002-04-30
EA005684B1 (ru) 2005-04-28
HUP0203275A3 (en) 2003-11-28
MXPA02004368A (es) 2002-11-14
CY1106672T1 (el) 2012-05-23
NO20022044D0 (no) 2002-04-30
KR20020063172A (ko) 2002-08-01
PT1228052E (pt) 2007-05-31
CN1264827C (zh) 2006-07-19
EA200200522A1 (ru) 2002-10-31
HK1049160A1 (en) 2003-05-02
JP4043236B2 (ja) 2008-02-06
WO2001032640A1 (en) 2001-05-10
DE69936004T2 (de) 2008-01-10
IL149401A (en) 2008-03-20
EP1228052A1 (en) 2002-08-07
HUP0203275A2 (hu) 2003-01-28
CA2389325C (en) 2007-01-09
CA2389325A1 (en) 2001-05-10
JP2003513083A (ja) 2003-04-08
EP1228052B1 (en) 2007-05-02
DK1228052T3 (da) 2007-06-18
ES2285870T3 (es) 2007-11-16
IL149401A0 (en) 2002-11-10
ATE361284T1 (de) 2007-05-15
SI1228052T1 (sl) 2007-10-31
CN1374956A (zh) 2002-10-16

Similar Documents

Publication Publication Date Title
HK1049160A1 (en) 1-Amino-alkylcyclohexane compound nmda receptor antagonist
HUT56368A (en) Process for producing tricyclic compounds and pharmaceutical compositions comprising such compounds
EP1361220A4 (en) CYCLIC COMPOUNDS WITH THROMBOPOIETIN RECEPTAGONISM
KR20050085991A (en) Compounds exhibiting thrombopoietin receptor agonism
DE69831868D1 (en) Antithrombosemittel
WO2005058884A3 (en) Cyclopropane compounds and pharmaceutical use thereof
CA2344290A1 (en) Quinazoline derivatives
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
IL119729A0 (en) Heterocyclic compounds having tachykinin receptor antagonist activity pharmaceutical compositions containing the same and processes for the preparation thereof
AU2337197A (en) Cinnamic acid derivatives and their use as integrin antagonists
CA2360360A1 (en) Piperidyl benzamide compounds, composition containing same and their use thereof
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
HK1052697A1 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same.
IL125982A0 (en) 2-(arylphenyl) amino-imidazoline derivatives
MX2023001725A (es) Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmaceuticos de los mismos.
IL108970A0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
HUT60491A (en) Process for producing substituted n-benzylindole derivatives having leukotriene antagonist effect and pharmaceutical compositions comprising such compounds
HUT61018A (en) Process for producing 3-/1-thiazolidinylbutyl-4-piperazinyl/1-h-indazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
CR20230218A (es) Nuevos derivados de indazol acetileno
EP1559707A4 (en) SPIRO COMPOUNDS, MEDICINAL COMPOSITIONS CONTAINING THE SAID COMPOUNDS AND INTERMEDIATES THEREOF
WO2005049559A3 (en) Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3)
CA2335394A1 (en) Aerothricin analogs, their preparation and use
KR930703275A (ko) 벤조옥사디논유도체
AR023701A1 (es) Compuestos de 1-cicloamin-alquilciclohexano, composiciones farmaceuticas de los mismos, metodo de tratamiento de las convulsiones y de preparacion de los compuestos, y su uso como anticonvulsivos
YU38498A (sh) Derivati 2-(arilfenil)amino-imidazolina

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101101